THE INDUSTRY’S LARGEST MARKETPLACE FOR PHARMACEUTICALS
domestic-supply.org has been in operation for almost 30 years, acquiring 50’s of thousands of satisfied customers.
domestic-supply.org works very hard to establish trust with our customer. Our high-quality products and professional staff is testament to the legitimacy of our business practice.
Each brand is hand-selected and goes through a very thorough review process.
Quality is held in a very high regard at domestic-supply.org. To further legitimize these products, we do have a comprehensive
Featured
GHRP-2
ACTIVE HALF-LIFE 2.5 hours CLASSIFICATION Growth Hormone Secretagogue Receptor Agonist DOSAGE 100-300 mcg/day ..
Ultima-Cyp
ACTIVE HALF-LIFE 7-8 Days CLASSIFICATION Anabolic Steroid DOSAGE Men: 300-1500 mg/week ACNE Yes WATER RETENTIO..
PHARMADRO P 100
ACTIVE HALF-LIFE 1-1.5 days CLASSIFICATION Anabolic Steroid DOSAGE Men: 300-700 mg/week ACNE Yes ..
Dostinex
ACTIVE HALF-LIFE 63-68 hours CLASSIFICATION Prolactin Inhibitor DOSAGE 1-2 mg/week ACNE No WATE..
Iverheal 3 mg
PRODUCT CLASSIFICATION Anti-Parasitic Agent MANUFACTURER Healing Pharma WAREHOUSE LOCATION International Warehouse 1 ..
Testosterone-Equipoise Blend 400
ACTIVE HALF-LIFE 14-16 days CLASSIFICATION Anabolic Steroid DOSAGE Recommended for men: 250-600 mg/week A..
Ment 50
ACTIVE HALF-LIFE 8-12 hours CLASSIFICATION Anabolic Steroid DOSAGE Men: 50 mg/day ACNE Rarely WA..
Humalog 100IU (Cart)
CLASSIFICATION Hormone & Synthetic Substitute / Antidiabetic Agent ACNE No WATER RETENTION No HBR No HEPATOTOXICITY No AROMATIZATION No MANUFACT..
Tamilong 20
ACTIVE HALF-LIFE 5-7 Days CLASSIFICATION SERM DOSAGE 20-40 mg/day ACNE No WATER RETENTION No ..
Clomid
ACTIVE HALF-LIFE 5-7 Days CLASSIFICATION Selective Estrogen Receptor Modulator (SERM) DOSAGE 50-100 mg/day ACNE None..
Ultima-Primo Tabs 25
ACTIVE HALF-LIFE 4-6 hours CLASSIFICATION Anabolic Steroid RECOMMENDED DOSAGE For men: 50-100 mg/day ACNE RISK Rarel..
PT-141
PRODUCT CLASSIFICATION Melanocortin Receptor Agonists ACNE POTENTIAL Not Applicable WATER RETENTION None HBR ..